1. Home
  2. ITRM vs LGCL Comparison

ITRM vs LGCL Comparison

Compare ITRM & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • LGCL
  • Stock Information
  • Founded
  • ITRM 2015
  • LGCL 2009
  • Country
  • ITRM Ireland
  • LGCL China
  • Employees
  • ITRM N/A
  • LGCL 361
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • LGCL
  • Sector
  • ITRM Health Care
  • LGCL
  • Exchange
  • ITRM Nasdaq
  • LGCL NYSE
  • Market Cap
  • ITRM 49.5M
  • LGCL 44.3M
  • IPO Year
  • ITRM 2018
  • LGCL 2024
  • Fundamental
  • Price
  • ITRM $1.75
  • LGCL $0.51
  • Analyst Decision
  • ITRM Strong Buy
  • LGCL
  • Analyst Count
  • ITRM 1
  • LGCL 0
  • Target Price
  • ITRM $5.00
  • LGCL N/A
  • AVG Volume (30 Days)
  • ITRM 1.6M
  • LGCL 481.8K
  • Earning Date
  • ITRM 11-14-2024
  • LGCL 11-22-2024
  • Dividend Yield
  • ITRM N/A
  • LGCL N/A
  • EPS Growth
  • ITRM N/A
  • LGCL 11.49
  • EPS
  • ITRM N/A
  • LGCL 0.14
  • Revenue
  • ITRM N/A
  • LGCL $173,306,912.00
  • Revenue This Year
  • ITRM N/A
  • LGCL N/A
  • Revenue Next Year
  • ITRM N/A
  • LGCL N/A
  • P/E Ratio
  • ITRM N/A
  • LGCL $4.05
  • Revenue Growth
  • ITRM N/A
  • LGCL N/A
  • 52 Week Low
  • ITRM $0.81
  • LGCL $0.51
  • 52 Week High
  • ITRM $3.02
  • LGCL $5.00
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 45.98
  • LGCL N/A
  • Support Level
  • ITRM $1.78
  • LGCL N/A
  • Resistance Level
  • ITRM $1.95
  • LGCL N/A
  • Average True Range (ATR)
  • ITRM 0.30
  • LGCL 0.00
  • MACD
  • ITRM -0.10
  • LGCL 0.00
  • Stochastic Oscillator
  • ITRM 0.00
  • LGCL 0.00

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About LGCL LUCAS GC LIMITED

Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.

Share on Social Networks: